Calvin Sandra

Track

Insider profile

Performance

Overall performance
2.9
Performance over holding periods
2.9
30 days 90 days 120 days
Average return 6% 8.2% 15.1%
Success rate 83% 68% 82%
Transactions
15 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Calvin Sandra's trades of Travere Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-04-16 2026-04-14
PlS Planned sale
58,723 +43.4%
68.38
US$4,597,713 		58,723 +43.4% 68.38 US$4,597,713
2026-04-14 2026-04-14
PrS Proposed sale
36,116
210.56
US$4,907,597 		36,116 210.56 US$4,907,597
2026-02-03 2026-02-03
S Sale
25,780 -10.7%
43.34
US$30,691 		25,780 -10.7% 43.34 US$30,691
2026-02-03 2026-02-03
PrS Proposed sale
4,333
32.12
US$139,177 		4,333 32.12 US$139,177
2026-02-03 2026-02-03
S Sale
4,333 -8.1%
32.12
US$139,176 		4,333 -8.1% 32.12 US$139,176
2025-12-29 2025-12-24
PrS Proposed sale
7,402
40.00
US$296,080 		7,402 40.00 US$296,080
2025-12-29 2025-12-24
PlS Planned sale
7,402 -16.2%
40.00
US$296,080 		7,402 -16.2% 40.00 US$296,080
2025-12-16 2025-12-15
PlS Planned sale
2,910 -6.0%
36.00
US$104,760 		2,910 -6.0% 36.00 US$104,760
2025-12-15 2025-12-15
PrS Proposed sale
2,910
36.00
US$104,760 		2,910 36.00 US$104,760
2025-11-06 2025-11-04
PlS Planned sale
67,115 -58.0%
36.00
US$2,416,140 		67,115 -58.0% 36.00 US$2,416,140
2025-11-04 2025-11-04
PrS Proposed sale
67,115
36.00
US$2,416,140 		67,115 36.00 US$2,416,140
2025-02-12 2025-02-11
PlS Planned sale
9,244 -14.5%
25.00
US$231,100 		9,244 -14.5% 25.00 US$231,100
2025-02-12 2025-02-11
PlS Planned sale
15,000 -19.1%
25.00
US$375,000 		15,000 -19.1% 25.00 US$375,000
2025-02-12 2025-02-11
PlS Planned sale
10,000 -13.6%
25.00
US$250,000 		10,000 -13.6% 25.00 US$250,000
2025-02-12 2025-02-11
PlS Planned sale
10,000 -13.6%
25.00
US$250,000 		10,000 -13.6% 25.00 US$250,000
2025-02-12 2025-02-11
PlS Planned sale
10,000 -13.6%
25.00
US$250,000 		10,000 -13.6% 25.00 US$250,000
2025-02-11 2025-02-11
PrS Proposed sale
54,244
25.00
US$1,356,100 		54,244 25.00 US$1,356,100
2025-02-04 2025-02-03
S Sale
3,348 -5.0%
20.12
US$67,362 		3,348 -5.0% 20.12 US$67,362
2025-02-03 2025-02-03
PrS Proposed sale
3,348
20.12
US$67,358 		3,348 20.12 US$67,358
2025-01-23 2025-01-22
S Sale
925 -1.7%
18.94
US$17,520 		925 -1.7% 18.94 US$17,520
2024-12-27 2024-12-26
PlS Planned sale
15,000 -21.5%
17.22
US$258,278 		15,000 -21.5% 17.22 US$258,278
2024-12-26 2024-12-26
PrS Proposed sale
15,000
17.22
US$258,278 		15,000 17.22 US$258,278
2024-11-25 2024-11-25
PrS Proposed sale
12,090
18.30
US$221,258 		12,090 18.30 US$221,258
2024-11-25 2024-11-25
S Sale
12,090 -18.0%
18.30
US$221,258 		12,090 -18.0% 18.30 US$221,258
2024-09-11 2024-09-11
PrS Proposed sale
15,000
14.80
US$222,000 		15,000 14.80 US$222,000
2024-02-02 2024-02-01
S Sale
2,820 -5.1%
8.53
US$24,058 		2,820 -5.1% 8.53 US$24,058
2024-01-25 2024-01-23
S Sale
910 -2.2%
9.07
US$8,252 		910 -2.2% 9.07 US$8,252
2023-05-12 2023-05-11
PlS Planned sale
122 -0.3%
16.12
US$1,967 		122 -0.3% 16.12 US$1,967
2023-05-12 2023-05-10
S Sale
436 -1.0%
16.59
US$7,233 		436 -1.0% 16.59 US$7,233
2023-02-02 2023-02-02
PlS Planned sale
360 -0.8%
22.42
US$8,071 		360 -0.8% 22.42 US$8,071
2023-02-02 2023-02-01
S Sale
1,671 -3.7%
21.75
US$36,348 		1,671 -3.7% 21.75 US$36,348
2023-01-26 2023-01-25
PlS Planned sale
192 -0.5%
21.63
US$4,153 		192 -0.5% 21.63 US$4,153
2023-01-26 2023-01-24
S Sale
905 -2.5%
21.90
US$19,823 		905 -2.5% 21.90 US$19,823
2022-09-15 2022-09-13
S Sale
349 -1.0%
28.00
US$9,772 		349 -1.0% 28.00 US$9,772
2022-05-12 2022-05-11
S Sale
445 -1.2%
21.92
US$9,756 		445 -1.2% 21.92 US$9,756
2022-05-12 2022-05-10
S Sale
436 -1.2%
21.51
US$9,378 		436 -1.2% 21.51 US$9,378
2022-02-02 2022-01-31
S Sale
798 -2.1%
26.51
US$21,152 		798 -2.1% 26.51 US$21,152
2022-01-26 2022-01-24
S Sale
934 -3.2%
24.58
US$22,955 		934 -3.2% 24.58 US$22,955